Gynesonics is developing proprietary minimally invasive devices for unmet needs in womens’ health. The company is developing a transcervical, ultrasound-guided ablation system for the treatment of uterine fibroids. It has received the CE mark in Europe.

Location Redwood City, California
CEO Chris Owens
Partner Ken Haas
Website www.gynesonics.com